 SOUTH PLAINFIELD, N.J., Dec. 4, 2020 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT today announced that on December 2, 2020 it approved non-statutory stock options to purchase an aggregate of 41,955 shares of its common stock and 20,735 restricted stock units RSUs, each... 